Company Filing History:
2 out of 5,094 
2 out of 23 Years Active: 2017-2018
Title: The Innovative Mind of Gilles Pages: A Pioneer in Antibody Research
Introduction
Gilles Pages, an esteemed inventor based in Monaco, MC, has made significant contributions to the field of biomedical innovation. With two patents to his name, Pages has demonstrated his expertise in developing crucial methodologies and antibodies that are pertinent to modern medical treatments.
Latest Patents
Among his notable inventions are the patents for Anti-CXCL1, CXCL7, and CXCL8 antibodies and their applications. This invention presents an isolated antibody or its fragment that targets human chemokines CXCL1, CXCL7, and CXCL8. These antibodies exhibit high binding affinity, characterized by an equilibrium dissociation constant (K) of at most 16 nM for CXCL1, 5 nM for CXCL7, and 45 nM for CXCL8, as evaluated through surface plasmon resonance. Moreover, Pages has developed a method for predicting patient response to treatments with HER2-blocking agents. This involves evaluating the nucleotide at the rs3746083 polymorphic site within the tristetraprolin protein gene in biological samples from patients suffering from HER2-positive cancer.
Career Highlights
Gilles Pages has excelled in his career, having worked at prestigious institutions such as the Centre National de la Recherche Scientifique and the Université de Nice-Sophia Antipolis. His roles at these organizations have paved the way for his innovative breakthroughs in antibody research, particularly in the context of cancer treatment.
Collaborations
Throughout his career, Pages has collaborated with notable professionals, including Renaud Grepin, enhancing the depth and application of his research. These partnerships have not only contributed to the advancement of scientific knowledge but have also provided cancer patients with new prospects for effective treatments.
Conclusion
Gilles Pages stands out as a prominent figure in the realm of inventions related to antibody applications and cancer treatments. His dedication to research and collaboration continues to influence the biomedical field, with his patented technologies expected to play a pivotal role in future medical advancements. His work exemplifies the impact that innovative minds can have on improving healthcare outcomes.